A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/51 (2006.01) A61K 38/19 (2006.01)
Patent
CA 2730841
The present invention relates to nanoparticles comprising osteopontin and a polymer carrier, preferably a cationic carrier. Preferably, the cationic carrier is chitosan. Osteopontin and/or the cationic carrier may have bioactivity and/or the nanopar- ticle may comprise an additional component with bioactivity. Such additional bioactive component may e.g. be a siRNA. The nanoparticles of the invention may be used for treatment of bone diseases or inflammatory diseases.
L'invention concerne des nanoparticules comprenant de l'osthéopontine, et un support polymère, de préférence un support cationique. De préférence, le support cationique est du chitosane. L'osthéopontine et/ou le support cationique peuvent présenter une bioactivité et/ou la nanoparticule peut comprendre un constituant supplémentaire présentant une bioactivité. Un tel constituant supplémentaire bioactif peut être par exemple un ARNsi. Les nanoparticules de l'invention peuvent servir à traiter des maladies osseuses ou des maladies inflammatoires.
Alan Howard Kenneth
Andreasen Morten
Besenbacher Flemming
Kjems Jørgen
Aarhus Universitet
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Osteopontin nanoparticle system for drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Osteopontin nanoparticle system for drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteopontin nanoparticle system for drug delivery will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1534702